Cinctive Capital Management’s Core Scientific, Inc. Common Stock CORZ Stock Holding History

Cinctive Capital Management’s Portfolio CORZ Stock Details CORZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,538	Closed	-$115K	–	695
2021 Q4	$115K	Sell	10,538 -64,456	-86%	-$760K	0.01%	491
2021 Q3	$758K	Sell	74,994 -100,000	-57%	-$1M	0.04%	428
2021 Q2	$1.72M	Buy	+174,994	New	+$1.72M	0.08%	303

Other funds holding CORZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PWM

Perigon Wealth Management San Francisco, California $5.51B AUM 24.51% 1-Year Est. Return

Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

HKAM

Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return

KCM

Kensico Capital Management Greenwich, Connecticut $4.9B AUM 41.26% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Cinctive Capital Management's CORZ Position: Q1 2022 in Review

Cinctive Capital Management sold out of Core Scientific, Inc. Common Stock (CORZ) in Q1 2022, closing a stake of 10,538 shares — an estimated $115K sold.

Cinctive Capital Management first reported a position in CORZ in Q2 2021 and held it in 3 quarters. The position peaked at $1.72M in Q2 2021. 91 funds tracked by Wall St. Rank hold CORZ as of Q1 2022.

Cinctive Capital Management reported no remaining Core Scientific, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Cinctive Capital Management sold 10,538 Core Scientific, Inc. Common Stock shares in Q1 2022, an estimated $115K.
Cinctive Capital Management first reported a position in Core Scientific, Inc. Common Stock in Q2 2021 and held it in 3 quarters.
Cinctive Capital Management's Core Scientific, Inc. Common Stock position peaked at $1.72M in Q2 2021.
91 funds tracked by Wall St. Rank held Core Scientific, Inc. Common Stock as of Q1 2022.

Based on Cinctive Capital Management's 13F filing for Q1 2022, filed 16 May 2022.